Last reviewed · How we verify
betamethasone and Ropivacaine
Betamethasone is a corticosteroid that reduces inflammation, while Ropivacaine is a local anesthetic that blocks nerve signals.
Betamethasone is a corticosteroid that reduces inflammation, while Ropivacaine is a local anesthetic that blocks nerve signals. Used for Postoperative pain management.
At a glance
| Generic name | betamethasone and Ropivacaine |
|---|---|
| Sponsor | Biobizkaia Health Research Institute |
| Drug class | Corticosteroid and Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
Betamethasone works by inhibiting the production of inflammatory mediators, thereby reducing swelling and pain. Ropivacaine, on the other hand, blocks sodium channels in nerve fibers, preventing the transmission of pain signals to the brain.
Approved indications
- Postoperative pain management
Common side effects
- Nausea
- Vomiting
- Headache
- Dizziness
- Paresthesia
Key clinical trials
- Clinical Trial to Evaluate the Efficacy and Safety of Platelet-rich Plasma Infiltration in Chronic Omalgia (PHASE3)
- Ropiclobet for Regional Anesthesia and Post-Operative Pain Control in Upper Extremity Surgery (PHASE2)
- Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery (NA)
- Phase I Study of Ropivacaine, Clonidine, and Betamethasone Combination for Sciatic Nerve Block in the Popliteal Region (PHASE1)
- Analgesic Efficacy of Preemptive Stepwise Infiltration Anesthesia for Perioperative Analgesia After TKA (NA)
- Predicting Response to Interventional Pain Management Techniques in Chronic Low Back Pain in a Prospective Cohort.
- Preemptive Infiltration With Betamethasone and Ropivacaine for Postoperative Pain in Laminoplasty or Laminectomy (PHASE4)
- Efficacy of Compound Betamethasone Injection Combined With Ropivacaine in Ultrasound-guided Intercostal Nerve Block for Chronic Post-thoracotomy Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- betamethasone and Ropivacaine CI brief — competitive landscape report
- betamethasone and Ropivacaine updates RSS · CI watch RSS
- Biobizkaia Health Research Institute portfolio CI